-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
[Generic Name] Linezolid Glucose Injection
[Approval Number] National Drug Approval Number H20213558
【Specification】100 ml: Linezolid 0.2 g and glucose (calculated as C6H12O6) 4.57 g
[Packaging Material] Three-layer co-extruded film for infusion (outer layer: polyester/aluminum/polyethylene pharmaceutical composite film bag)
[Medical Insurance] National Medical Insurance Category B
Category:
Tags:
- Product Description
- parameter
-
- Commodity name: Linezolid Glucose Injection
- Commodity ID: 1468517174946189312
<p> [Generic Name] Linezolid Glucose Injection </p> <p> [Approval Number] National Drug Approval Number H20213558 </p> <p> 【Specification】100 ml: Linezolid 0.2 g and glucose (calculated as C6H12O6) 4.57 g </p> <p> [Packaging Material] Three-layer co-extruded film for infusion (outer layer: polyester/aluminum/polyethylene pharmaceutical composite film bag) </p> <p> [Medical Insurance] National Medical Insurance Category B </p>
[Generic Name] Linezolid Glucose Injection
[Approval Number] National Drug Approval Number H20213558
[Specification] 100 ml: Linezolid 0.2 g and glucose (calculated as C6H12O6) 4.57 g
[Packaging Material] Three-layer co-extruded film infusion bag (outer layer: polyester/aluminum/polyethylene pharmaceutical composite film bag)
[Medical Insurance] National Medical Insurance Category B
-
-
Contact phone number
-
Related products
undefined
Product Message
* If you have any comments or suggestions, feel free to leave us a message. We’ll serve you wholeheartedly and respond to you as soon as possible.
SERVICE HOTLINE
Mobile site
E code
